Close Menu

NEW YORK – Gritstone Oncology, an Emeryville, California-based company developing personalized immunotherapies, on Monday said it has raised $125 million from two private placements of its publicly traded shares.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.